The Head of the Department of Clinical Pharmacy at the College of Pharmacy, Al-Nahrain University, Dr. Muhannad Abdul Sahib Zabon, has published a scientific paper in the peer-reviewed journal Health and Medical Research Advances, which specializes in publishing contemporary medical and pharmaceutical research.

📚 Research Title:
Preliminary Effect of Anthracycline Type and Dose on Remission Induction Outcomes in Adult Acute Myeloid Leukemia

🎯 Objective:
The study aims to evaluate the response of adult patients with acute myeloid leukemia (AML) to the standard treatment protocol (3+7), and to examine the impact of the type and dosage of anthracycline drugs on complete remission rates and overall survival.

🔬 Key Aspects of the Study:
● A prospective clinical study on newly diagnosed patients in Baghdad
● Comparison between two treatment types (Daunorubicin and Doxorubicin)
● Analysis of the effect of dose variation on treatment response rates
● Evaluation of survival rates using advanced statistical methods
● Assessment of chemotherapy-related side effects

📊 Key Results:
● A complete remission rate of (62.3%) among patients
● A higher dose of Daunorubicin (90 mg/m²) demonstrated better therapeutic response
● No statistically significant difference in survival based on drug type, with a slight advantage for Daunorubicin

✨ This achievement comes as part of the ongoing efforts of the College of Pharmacy at Al-Nahrain University to promote high-quality scientific research and support clinical studies that contribute to advancing healthcare practices and services in Iraq.

#Media and Government Communication Unit
College of Pharmacy – Al-Nahrain University